Loading…
ERDOTIN is a brand name for Erdosteine. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: As an expectorant. For the symptomatic treatment of acute exacerbations of chronic bronchitis in adults.
Verbatim from this product's MHRA label. Tap a section to expand.
Elderly and adults above 18 years: 300 mg twice daily for maximum 10 days. The capsules must be swallowed whole with a glass of water.
Nervous system disorders Uncommon (1/1,000 to Headache Respiratory, thoracic and mediastinal disorders Uncommon (1/1,000 to <1/100) Cold, dyspnoea Gastrointestinal disorders Uncommon (1/1,000 to <1/100) Common (1/100 Taste alterations, nausea, vomiting, diarrhoea Epigastric painSkin and subcutaneous tissue disorders Uncommon ((1/1,000 to <1/100) Angioedema and cutaneous hypersensitivity reactions, such as urticaria, erythema, oedema and eczema Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important.
It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard.
No increase in adverse events has been observed with erdosteine in patients with mild liver failure; however these patients should not exceed a dose of 300 mg per day.
Hypersensitivity to the active substance or to any of the other excipients. Since there are no data in patients with creatinine clearance <25ml/min, or with severe liver failure, the use of erdosteine is not recommended in these patients.
Patients with active peptic ulcer.
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.